Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001254
Status:
COMPLETED
Last Update Posted:
2024-06-21
First Post:
1999-11-03
Brief Title:
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome
Status:
COMPLETED
Status Verified Date:
2024-08-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This protocol concerns the approach to the localization diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome It details the diagnostic imaging tests to be used to localize the tumor investigations for MEN1 the subsequent management of the tumor and tissue samples for research
Detailed Description:
This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 90-DK-0137 | None | None | None |